SOX2 and cancer: To investigate whether the SRR124–134 cluster drives SOX2 expression in cancer cells, we used CRISPR/Cas9 to delete this cluster from breast (MCF-7, T47D) and lung (H520, PC-9) cancer cell lines (Supplementary Figure S2A).